Information regarding specific Trelegy Ellipta coupons for 2023 is not publicly available. Patient assistance programs are typically managed by pharmaceutical manufacturers.
How can I find savings for Trelegy Ellipta?
Patients seeking to reduce the cost of Trelegy Ellipta may find savings through manufacturer-sponsored discount programs, such as the Trelegy Ellipta Savings Card, if available [1]. Eligibility for these programs often depends on insurance status and income. Information on current offers and terms can usually be found on the drug's official website or through patient support services.
What is Trelegy Ellipta used for?
Trelegy Ellipta is a once-daily triple-therapy medication used for the long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is also indicated for the maintenance treatment of asthma in adult patients aged 18 years and older for whom an inhaled corticosteroid and long-acting beta2-agonist is not sufficient [2].
How does Trelegy Ellipta work?
Trelegy Ellipta contains three active ingredients: fluticasone furoate, a corticosteroid that reduces inflammation; umeclidinium, a long-acting muscarinic antagonist (LAMA) that relaxes airway muscles; and vilanterol, a long-acting beta2-agonist (LABA) that also helps relax airway muscles [2]. This combination works to improve breathing in people with COPD and asthma.
When does Trelegy Ellipta's patent expire?
Patent expiration dates for pharmaceuticals are complex and can involve multiple patents covering the drug substance, formulation, and methods of use. A general overview of patent information, including potential expiration timelines for drugs like Trelegy Ellipta, can be found on resources such as DrugPatentWatch.com [3]. Specific patent details and their expiration dates are subject to legal challenges and regulatory processes.
Who makes Trelegy Ellipta?
Trelegy Ellipta is manufactured by GlaxoSmithKline (GSK) [2].
---
1. Trelegy Ellipta Savings Card. GSK.
2. Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol) inhalation powder. U.S. Food and Drug Administration.
3. DrugPatentWatch.com.